Chicago Department of Public Health, Chicago, Illinois, USA.
J Infect Dis. 2024 Mar 26;229(Supplement_2):S207-S212. doi: 10.1093/infdis/jiad531.
This report summarizes risk assessment interviews and follow-up with health care personnel (HCP) after exposure to patients with mpox disease during 17 May to 8 July 2022. HCP-case interactions were assessed using a standard questionnaire to categorize the risk associated with patient encounters. We assessed 150 interactions among 142 HCP and 30 cases. Four (2.7%) interactions were defined as high risk, 5 (3.3%) intermediate, 107 (71.3%) low, and 31 (20.7%) no risk. High and intermediate exposures were offered postexposure prophylaxis; 4 accepted. No documented mpox transmission after exposure was identified. These findings suggest transmission risk in health care settings during routine patient care is low.
本报告总结了 2022 年 5 月 17 日至 7 月 8 日期间,在接触患有猴痘疾病的患者后,对医护人员(HCP)进行的风险评估访谈和随访。使用标准问卷评估了 HCP-病例之间的相互作用,以对与患者接触相关的风险进行分类。我们评估了 142 名 HCP 和 30 例病例之间的 150 次相互作用。其中 4 次(2.7%)被定义为高风险,5 次(3.3%)为中风险,107 次(71.3%)为低风险,31 次(20.7%)为无风险。对高风险和中风险暴露者提供了接触后预防措施;4 人接受。未发现接触后有猴痘传播的记录。这些发现表明,在常规患者护理期间,医护人员在医疗保健环境中的传播风险较低。